Cardiac Safety and Trauma Trial Design Subject Of Hemopure Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Blood Products Advisory Committee review could give the agency the green light to lift the clinical hold on the hemoglobin-based oxygen therapeutic.